Growth rate alone and profitability alone each tell an incomplete story about a company’s genuine health — a company growing extremely fast while burning enormous amounts of cash and one growing slowly but generating strong margins can both be either genuinely healthy or genuinely concerning, depending on factors neither metric captures in isolation. The Rule of 40 and related composite health metrics combine both dimensions into a more complete picture.
What the Rule of 40 Actually Measures
The Rule of 40 states that a healthy growth-stage company’s revenue growth rate plus its profit margin (typically measured as free cash flow margin or EBITDA margin) should sum to 40% or more — a company growing at 60% annually with a negative 10% margin passes comfortably (50%); a mature company growing at just 10% with a 35% margin also passes (45%); but a company growing at 25% with a negative 20% margin falls short (5%) and warrants a closer look. The specific combination matters less than the sum crossing the threshold.
Why Combining Growth and Profitability Reveals More Than Either Alone
A company can be growing impressively while burning cash unsustainably, or can be highly profitable while stagnating and losing genuine market position — the Rule of 40 forces an explicit tradeoff conversation: is aggressive, cash-burning growth genuinely justified by the growth rate achieved, or is a company using profitability as cover for genuinely inadequate growth momentum.
Applying the Rule of 40 to Your Own Company's Stage
Very early-stage companies genuinely should prioritize growth heavily over profitability, since establishing market position and product-market fit matters more at this stage than near-term margin — the Rule of 40 becomes a more relevant, applicable benchmark once a company has reached genuine growth-stage maturity with a reasonably proven, scaling business model, rather than being a meaningful target from day one.
Using the Framework to Guide Strategic Tradeoff Decisions
- A company well below the 40% threshold with strong growth but weak margin should honestly assess whether the growth rate genuinely justifies the cash burn, or whether some deliberate margin improvement is warranted even at some growth rate cost.
- A company well below the threshold with strong margin but weak growth should honestly assess whether excessive caution is limiting genuine growth opportunity that additional, deliberate investment could unlock.
- A company comfortably above the threshold has more genuine strategic flexibility to lean further toward either growth or margin, depending on genuine strategic priority and market opportunity.
Limitations of the Rule of 40 Worth Understanding
The framework was developed primarily in a SaaS and software context, and its direct applicability to other business models (physical products, services with different cost structures) varies — treat it as a useful directional framework for growth-stage software-adjacent businesses specifically, rather than a universal law applicable identically across every business type and industry.
Other Health Metrics Worth Tracking Alongside the Rule of 40
- Net revenue retention, revealing whether existing customer revenue is growing or shrinking over time independent of new customer acquisition, a genuine health signal the Rule of 40 doesn’t directly capture.
- CAC payback period, covered specifically elsewhere, revealing genuine cash sustainability of the growth engine itself, complementary to but distinct from the Rule of 40’s broader combined metric.
- Gross margin trend, since a company can hit Rule of 40 targets through revenue growth while gross margin quietly erodes, a concerning trend the composite metric alone wouldn’t surface.
Using the Rule of 40 in Investor and Board Conversations
This framework is genuinely widely recognized among growth-stage investors, making it a useful shared reference point for conversations about the appropriate growth-versus-profitability tradeoff at your current stage — framing strategic discussions around this shared, recognized benchmark can produce more productive conversation than each stakeholder bringing entirely different individual mental models to the discussion.
Tracking Your Own Trend Over Time
Beyond a single-point calculation, tracking your Rule of 40 score’s trend over successive quarters reveals whether the business is genuinely moving toward healthier combined growth-and-profitability balance or drifting further from it, providing more useful signal than any single-period snapshot alone.
Where This Fits the Broader Strategy
The Rule of 40 combines growth and profitability into a more complete health signal than either metric alone provides, particularly useful for growth-stage companies navigating genuine strategic tradeoffs between the two. For the complete strategic framework, see our complete growth strategy guide for scaling a business.
Growth alone and profitability alone each tell an incomplete story — a combined health metric like the Rule of 40 forces the honest tradeoff conversation that either metric in isolation lets a company avoid.
